Neuropsychiatric Symptoms Predict Faster Cognitive Decline in Dementia Collaborative Care Than Antipsychotic Use
Yen-Jen Chen,Ming-Che Chang,Kai-Ming Jhang,Wen-Fu Wang,Yi-Cheng Liao
DOI: https://doi.org/10.2147/ndt.s454943
IF: 2.989
2024-03-27
Neuropsychiatric Disease and Treatment
Abstract:Yen-Jen Chen, 1, 2, &ast Ming-Che Chang, 3, &ast Kai-Ming Jhang, 4, &ast Wen-Fu Wang, 4, &ast Yi-Cheng Liao 1 1 Department of Psychiatry, Changhua Christian Hospital, Changhua, Taiwan; 2 Department of Psychiatry, Yuanlin Christian Hospital, Changhua, Taiwan; 3 Department of Nuclear Medicine, Changhua Christian Hospital, Changhua, Taiwan; 4 Department of Neurology, Changhua Christian Hospital, Changhua, Taiwan &astThese authors contributed equally to this work Correspondence: Yi-Cheng Liao, Department of Psychiatry, Changhua Christian Hospital, 135, Nan-Xiao St, Changhua, 500, Taiwan, Tel +886 4 7238595 ext. 7160, Fax +886 4-7251004, Email Background: To compare short-term cognitive outcomes among groups with and without neuropsychiatric symptoms (NPSs) or antipsychotic prescription and to determine which disease status or treatment modality is associated with relatively faster cognitive decline. Methods: We retrospectively analyzed a prospective cohort of patients diagnosed with dementia and mild cognitive impairment. All participants were evaluated using the Cognitive Abilities Screening Instrument (CASI) during their initial clinical assessments and at the annual follow-up. The dependent variable was annual delta CASI. Multivariate linear regression analysis was used to assess the degree of association between NPS, antipsychotic use, and cognitive decline after adjusting for confounding factors. Neuropsychiatric symptoms were examined individually to determine their predictive value for cognitive decline. Results: A total of 407 (N = 407) patients were included in the study. NPSs, rather than antipsychotic use, led to faster cognitive decline. A higher baseline NPI total score predicted a significantly faster decline in CASI scores (1-year delta CASI = − 0.22, 95% CI = − 0.38~ − 0.05, p = 0.010). Specific items (delusions, agitation, depression, anxiety, euphoria, and apathy) in the NPS significantly increased cognitive decline. Conclusion: Certain neuropsychiatric symptoms, rather than antipsychotic use, lead to faster cognitive decline in a dementia collaborative care model. Checking for and providing appropriate interventions for NPS in people with dementia and their caregivers are highlighted. Keywords: neuropsychiatric symptoms, antipsychotics, cognitive decline, cognitive abilities screening instrument, dementia collaborative care Neuropsychiatric symptoms (NPSs) are behavioral (eg aberrant motor behavior) and psychological (eg delusion or hallucination) symptoms. They hold a high prevalence in patients with dementia and occur frequently during the course of cognitive decline. In addition to dementia caused by Alzheimer's disease (AD), NPSs are common across various types of dementia. 1–3 In our previous study on the institutionalization risks for patients with dementia in Taiwan, we found that the presence of NPSs at entry into dementia collaborative care is a significant predictor. 4 Institutionalization partially reflects dementia progression 5 and provides indirect evidence of the speed of progression. Surveillance of longitudinal changes in dementia severity are essential for providing individualized care plans. A longitudinal survey of neuropsychological functions predicts the prognosis of patients with cognitive impairment. 6 Factors associated with faster neurocognitive progression warrant further confirmation and may serve as a pivotal role for continuous care directions. A case management model in dementia care has been reported to reduce the prevalence of neuropsychiatric symptoms. 7,8 The use of psychotropic medications is significantly associated with a high severity of NPS. 9 Decreasing the severity of NPS can be achieved with both a cognitive-behavioral approach 10 and psychotropic use. 11 Increasing evidence has shown that the conversion rate of mild cognitive impairment (MCI) to dementia is higher in patients with more severe NPS. 12,13 Certain types of NPSs are predictors of progression to AD. 14 The prevalence of NPSs is associated with an increased rate of cognitive decline, even in older adults without dementia. 15 Antipsychotic use has been postulated to predict cognitive decline; 16 however, confounding effect of the indication should be taken into account. NPSs are significant factors for families to recognize the progression of dementia. 17 NPS severity is associated with caregiver stress and therapeutic outcomes. 18 Furthermore, neuropsychiatric symptoms are associated with h -Abstract Truncated-
psychiatry,clinical neurology